Maria del Carmen F. Á.
- Country
- Spain
- Department
- UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Research Overview
- Comparative Efficacy of Temocillin Sodium Versus Meropenem and Ertapenem Sodium in Treating Enterobacteriaceae Bacteremia Resistant to Third-Generation Cephalosporins
- Non-Inferiority Trial Comparing 7-Day Versus 14-Day Linezolid and Drug Combination Regimens for Uncomplicated Enterococcal Bacteremia
- Evaluation of Antiviral Efficacy, Safety, and Pharmacokinetics of VH4524184 in Treatment-Naïve Adults with HIV-1: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 15 of 30 partner sites.
Specializations
Bacterial Infections
Specializes in investigating therapeutic approaches for enterococcal infections, with particular focus on E. faecalis and E. faecium bacteremia. Conducts research on treatment optimization for Enterobacteriales infections.
- Bacteremia Management
- Antibiotic Treatment Strategies
- Enterococcal Disease
Explores comparative effectiveness of different antibiotic regimens and treatment durations.
Cardiovascular Infections
Focuses on treating infective endocarditis caused by specific pathogens. Investigates innovative approaches in post-cardiac surgery infections, particularly in relation to cytomegalovirus management in high-risk patients.
- Endocarditis Treatment
- Cardiac Surgery Complications
- Antiviral Strategies
Develops protocols for preemptive therapy in cardiac surgery patients.
Viral Diseases
Conducts research in HIV-1 treatment with focus on treatment-naïve patients. Investigates novel therapeutic approaches for cytomegalovirus infections in immunocompetent individuals.
- HIV Therapeutics
- Antiviral Therapy
- Viral Load Management
Evaluates innovative antiviral compounds and treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.